Cargando…

Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

In recent years, immunotherapy-based regimens have been included into the treatment's algorithm of several cancer types. Programmed death-1 (PD-1) and cytotoxic T lymphocyte antigen-4 (CTLA-4) interact with their ligands found on the surface of antigen presenting cells (APC) or tumor cells (PD-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iranzo, Patricia, Callejo, Ana, Assaf, Juan David, Molina, Gaspar, Lopez, Daniel Esteban, Garcia-Illescas, David, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Cedres, Susana, Carbonell, Caterina, Frigola, Joan, Amat, Ramon, Felip, Enriqueta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189307/ https://www.ncbi.nlm.nih.gov/pubmed/35707528 http://dx.doi.org/10.3389/fmed.2022.875974

Ejemplares similares

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
por: Callejo, Ana, et al.
Publicado: (2021)

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
por: Frigola, Joan, et al.
Publicado: (2022)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
por: Cedres, Susana, et al.
Publicado: (2021)

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
por: Carbonell, Caterina, et al.
Publicado: (2023)

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Frigola, Joan, et al.
Publicado: (2021)

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
por: Cedres, Susana, et al.
Publicado: (2023)

MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
por: Cedres, S., et al.
Publicado: (2021)

Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2022)

Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
por: Cedrés, Susana, et al.
Publicado: (2015)

Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
por: Martinez, Pablo, et al.
Publicado: (2013)

Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation
por: Cedrés, Susana, et al.
Publicado: (2018)

PI3K Pathway in NSCLC
por: Martinez-Martí, Alex, et al.
Publicado: (2012)

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
por: Riveiro-Barciela, Mar, et al.
Publicado: (2023)

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
por: Valencia, Karmele, et al.
Publicado: (2022)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
por: Felip, Enriqueta, et al.
Publicado: (2008)

Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
por: Gridelli, Cesare, et al.
Publicado: (2011)

Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
por: Oleas, Diana, et al.
Publicado: (2020)

Rectal Metastases from Squamous Cell Carcinoma: A Case Report and Review of the Literature
por: Cedrés, S., et al.
Publicado: (2012)

Overview of virus and cancer relationships. Position paper
por: Bouza, Emilio, et al.
Publicado: (2021)

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer
por: Dienstmann, Rodrigo, et al.
Publicado: (2011)

Toxicities associated with checkpoint inhibitors—an overview
por: Spiers, Laura, et al.
Publicado: (2019)

Variable interplay of UV-induced DNA damage and repair at transcription factor binding sites
por: Frigola, Joan, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
por: van Doorn, Diederick J., et al.
Publicado: (2020)

An overview of immune checkpoint inhibitors in breast cancer
por: Miglietta, Federica, et al.
Publicado: (2020)

Enantioselective Synthesis of the Ethyl Analog of the Marine Alkaloid Haliclorensin C
por: Guignard, Guillaume, et al.
Publicado: (2019)

Factores de riesgo de deterioro cognitivo asociado a cáncer en pacientes con carcinoma de mama y colon que reciben tratamiento con quimioterapia
por: Iranzo, Patricia, et al.
Publicado: (2023)

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers
por: Bebb, D. Gwyn, et al.
Publicado: (2023)

An Overview of the Spindle Assembly Checkpoint Status in Oral Cancer
por: Teixeira, José Henrique, et al.
Publicado: (2014)

Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment
por: Pirš, Boštjan, et al.
Publicado: (2022)

Altered oncomodules underlie chromatin regulatory factors driver mutations
por: Frigola, Joan, et al.
Publicado: (2016)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
por: Martinez-Marti, A, et al.
Publicado: (2017)

Reduced mutation rate in exons due to differential mismatch repair
por: Frigola, Joan, et al.
Publicado: (2017)

Simple Organics and Biomonomers Identified in HCN Polymers: An Overview
por: Ruiz-Bermejo, Marta, et al.
Publicado: (2013)

Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
por: Li, Jingjing, et al.
Publicado: (2023)

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors
por: Barlesi, Fabrice, et al.
Publicado: (2022)

Experiment Control@LHC - An Overview
por: Gaspar, C
Publicado: (2013)

Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database
por: Ortiz de Landaluce, Leticia, et al.
Publicado: (2018)

An Overview of the LHC Experiments' Control Systems
por: Gaspar, C
Publicado: (2014)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
por: Dai, Xinlun, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vb39qj1ugm8lljmj5o831pfpbg